A Long Way to Go: A Scenario for Clinical Trials of PI3K Inhibitors in Treating Cancer.

Bárbara Adriana Ferreira Dos Santos Trigueiros Ivan José Santana Santos Fabricia Pires Pimenta Andréa Rodrigues Ávila

Published in: Cancer control : journal of the Moffitt Cancer Center (2024)

The establishment of development indicators based on clinical trials for cancer treatment was useful to highlight the clinical investment in 3 new PI3K drugs and the advantages of combine therapy using FDA-approved drugs.

Keyphrases

clinical trial
papillary thyroid
phase ii
squamous cell
open label
drug induced
phase iii
randomized controlled trial
mesenchymal stem cells
squamous cell carcinoma
bone marrow